1Mesotten D, van den Berghe G. Clinical potential of insulin therapy in critically ill patients. Drugs, 2003,63 : 625-636.
2Lewis KS, Kane-Gill SL, Bobek MB, et al. Intensive insulin therapy for critically ill patients. Ann Pharmacother,2004,38:1243-1251.
3Orford NR. Intensive insulin therapy in septic shock . Crit Care Resusc, 2006,8 : 230-234.
4Elan J, Laurel AO, Michael D, et al. The impact of hyperglycemia on patients with severe brain injury. Trauma,2005,58:47-50.
5Robinson LE, van Soeren MH. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. AACN Clin Issues,2004, 15:45- 62.
6Marik PE, Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Meal,2004,30: 748-756.
7Dunger D Yuen K, Ong K. Insulin-like growth factor I and impaired glucose tolerance. Horm Res,2004,62: 101-107.
8Montori VM, Bistfian BR, McMahon MM. Hyperglycemia in acutely ill patients. JAMA,2002,288:2167-2169.
9Waclllin G, Augstein P, Schroder D, et al. IL-lbeta, IFN-gamma and TNF- alpha increase vulnerabihtv of pancreatic beta cells to autoimmtme destruction. J Autoimmun, 2003,20:303-312.
10withers D J, Gutierrez JS, Towery H. et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature, 1998,391 : 900-904.
